Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease

Hepatology- United States

doi 10.1002/hep.29298

Full Text

Abstract

Available in

Categories

Date

August 26, 2017

Authors

Paola Dongiovanni

Publisher

Wiley

Related search

The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation

English

PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells

Hepatology Communications

English

The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells

English

The Rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia

International Journal of Biomedicine

English

PNPLA3 Gene and Kidney Disease

English

Pharmacological Interventions for Non-Alcohol Related Fatty Liver Disease (NAFLD)

Cochrane Database of Systematic Reviews

English

PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients With Non-Alcoholic Fatty Liver Disease

Multidisciplinary

English

Analysis of Polymorphic Options of the eNOS, PNPLA3, CD14 Genes at Alcoholic Liver Disease

Romanian Journal of Medical Practice

English

WIP1 Phosphatase as Pharmacological Target in Cancer Therapy

Journal of Molecular Medicine

Molecular Medicine

English